Western Blot: BSND Antibody [H00007809-B01P] - Analysis of BSND expression in 293.
Immunohistochemistry-Paraffin: BSND Antibody [H00007809-B01P] - Analysis of purified antibody to BSND on formalin-fixed paraffin-embedded human kidney. (antibody concentration 3 ug/ml)
Western Blot: BSND Antibody [H00007809-B01P] - Analysis of BSND expression in transfected 293T cell line by BSND polyclonal antibody. Lane 1: BSND transfected lysate(35.2 KDa). Lane 2: Non-transfected lysate.
Antibody reactivity against Recombinant Protein with GST tag on ELISA and WB and also on transfected lysate in WB. GST tag alone is used as a negative control. It has been used for IHC-P. Use in Immunohistochemistry reported in scientific literature (PMID: 28994389).
Read Publication using H00007809-B01P in the following applications:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
PBS (pH 7.4)
Protein A purified
Quality control test: Antibody reactive against mammalian transfected lysate.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for BSND Antibody
Bartter syndrome, infantile, with sensorineural deafness (Barttin)
deafness, autosomal recessive 73
This gene encodes an essential beta subunit for CLC chloride channels. These heteromeric channels localize to basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Mutations in this gene have been associated with Bartter syndrome with sensorineural deafness. [provided by RefSeq]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our BSND Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.